Find similiar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL32553/0001.
Zaponex 25 and 100 mg Tablets
ZAPONEX® 25 mg TABLETS
ZAPONEX® 100 mg TABLETS
Clozapine
1. What Zaponex is and what it is used for
2. What you need to know before you take Zaponex
3. How to take Zaponex
4. Possible side effects
5. How to store Zaponex
6. Contents of the pack and further information
The active ingredient of Zaponex is clozapine which belongs to a group of medicines called antipsychotics (medicines that are used to treat specific mental disorders such as psychosis).
Zaponex is used to treat people with schizophrenia in whom other medicines have not worked. Schizophrenia is a mental illness which affects how you think, feel and behave. You should only use this medicine if you have already tried at least two other antipsychotic medicines, including one of the newer atypical antipsychotics, to treat schizophrenia, and these medicines did not work, or caused severe side effects that cannot be treated.
Zaponex is also used to treat severe disturbances in the thoughts, emotions and behaviour of people with Parkinson’s disease in whom other medicines have not worked.
If any of the above applies to you, tell your doctor and do not take Zaponex.
Zaponex must not be given to anyone who is unconscious or in a coma.
The safety measures mentioned in this section are very important. You must comply with them to minimise the risk of serious life-threatening side effects.
Before you start treatment with Zaponex, tell your doctor if you have or ever had:
Before you start taking Zaponex, your doctor will ask about your medical history and do a blood test to ensure that your white blood cell count is normal. It is important to find this out, as your body needs white blood cells to fight infections.
Make sure that you have regular blood tests before you start treatment, during treatment and after you stop treatment with Zaponex.
Your doctor will also do a physical examination before starting treatment. Your doctor may do an electrocardiogram (ECG) to check your heart, but only if this is necessary for you, or if you have any special concerns.
If you have a liver disorder you will have regular liver function tests as long as you continue to take Zaponex. If you suffer from high levels of sugar in the blood (diabetes) your doctor may regularly check your level of sugar in the blood.
Zaponex may cause alteration in blood lipids. Zaponex may cause weight gain. Your doctor may monitor your weight and blood lipid level.
If you already feel that Zaponex makes you light-headed, dizzy or faint, be careful when getting up from a sitting or lying position, as this may increase the possibility of falling.
If you have to undergo surgery or if for some reason you are unable to walk around for a long time, discuss with your doctor the fact that you are taking Zaponex. You may be at risk of thrombosis (blood clotting within a vein).
If you are under 16 years of age you should not use Zaponex as there is not enough information on its use in that age group.
Older people (aged 60 years and over) may be more likely to have the following side effects during treatment with Zaponex: faintness or light-headedness after changing position, dizziness, fast heartbeat, difficulty in passing urine, and constipation.
Tell your doctor or pharmacist if you suffer from a condition called dementia.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription or herbal therapies. You might need to take different amounts of your medicines or take different medicines.
Do not take Zaponex together with medicines that stop the bone marrow from working properly and/or decrease the number of blood cells produced by the body, such as:
These medicines increase your risk of developing agranulocytosis (lack of white blood cells).
Tell your doctor if you plan to take, if you are taking (even if the course of treatment is about to end) or if you have recently had to stop taking any of the following medicines:
This list is not complete. Your doctor and pharmacist have more information on medicines to be careful with or to avoid while taking Zaponex. They will also know if the medicines you are taking belong to the listed groups. Speak to them.
Do not drink alcohol during treatment with Zaponex.
Tell your doctor if you smoke and how often you have drinks containing caffeine (coffee, tea, cola). Sudden changes in your smoking habits or caffeine drinking habits can also change the effects of Zaponex.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will discuss with you the benefits and possible risks of using this medicine during pregnancy. Tell your doctor immediately if you become pregnant during treatment with Zaponex.
Pregnancy
The following symptoms may occur in newborn babies, of mothers that have used Zaponex in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these symptoms you may need to contact your doctor.
Breast-feeding
Do not breast-feed during treatment with Zaponex. Clozapine, the active substance of Zaponex, may pass into your milk and affect your baby.
Some women taking some medicines to treat mental illnesses have irregular or no periods. If you have been affected in this way, your periods might return when your medicine is changed to Zaponex. This means you should use effective contraception.
Zaponex might cause tiredness, drowsiness and seizures, especially at the beginning of treatment.
You should not drive or operate machines while you have these symptoms.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Zaponex.
In order to minimise the risk of low blood pressure, seizures and drowsiness it is necessary that your doctor increases your dose gradually. Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
It is important that you do not change your dose or stop taking Zaponex without asking your doctor first. Continue taking the tablets for as long as your doctor tells you. If you are 60 years or older, your doctor may start you on a lower dose and increase it more gradually because you might be more likely to develop some unwanted side effects (see section 2 “Before you take Zaponex”).
If the dose you are prescribed cannot be achieved with this strength tablet, other strengths of this medicinal product are available to achieve the dose.
Zaponex tablets can be divided into equal doses.
The recommended starting dose is 12.5 mg (one half of a 25 mg tablet) once or twice on the first day followed by 25 mg once or twice on the second day. Swallow the tablet with water. If tolerated well, your doctor will then gradually increase the dose in steps of 25-50 mg over the next 2-3 weeks until a dose up to 300 mg per day is reached. Thereafter, if necessary, the daily dose may be increased in steps of 50 to 100 mg half-weekly or, preferably, at weekly intervals.
The effective daily dose is usually between 200 mg and 450 mg, divided into several single doses per day. Some people might need more. A daily dose of up to 900 mg is allowed. Increased side effects (in particular seizures) are possible at daily doses over 450 mg. Always take the lowest effective dose for you. Most people take part of their dose in the morning and part in the evening.
Your doctor will tell you exactly how to divide your daily dose. If your daily dose is only 200 mg, then you can take this as a single dose in the evening. Once you have been taking Zaponex with successful results for some time, your doctor may try you on a lower dose. You will need to take Zaponex for at least 6 months.
The recommended starting dose is 12.5 mg (one half of a 25 mg tablet) in the evening. Swallow the tablet with water. Your doctor will then gradually increase the dose in steps of 12.5 mg, not faster than two steps a week, up to a maximum dose of 50 mg by the end of the second week. Increases in the dosage should be stopped or postponed if you feel faint, light-headed or confused. In order to avoid such symptoms your blood pressure will be measured during the first weeks of treatment.
The effective daily dose is usually between 25 mg and 37.5 mg, taken as one dose in the evening.
Doses of 50 mg per day should only be exceeded in exceptional cases. The maximum daily dose is 100 mg. Always take the lowest effective dose for you.
If you think that you may have taken too many tablets, or if anyone else takes any of your tablets, contact a doctor immediately or call for emergency medical help.
The symptoms of overdose are:
Drowsiness, tiredness, lack of energy, unconsciousness, coma, confusion, hallucinations, agitation, incoherent speech, stiff limbs, trembling hands, seizures (fits), increased production of saliva, widening of the black part of the eye, blurred vision, low blood pressure, collapse, fast or irregular heartbeat, shallow or difficult breathing.
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, leave out the forgotten tablets and take the next dose at the right time. Do not take a double dose to make up for a forgotten dose. Contact your doctor as soon as possible if you have not taken any Zaponex for more than 48 hours.
Do not stop taking Zaponex without asking your doctor, because you might get withdrawal reactions. These reactions include sweating, headache, nausea (feeling sick), vomiting (being sick) and diarrhoea. If you have any of the above signs, tell your doctor straight away. These signs may be followed by more serious side effects unless you are treated immediately. Your original symptoms might come back. A gradual reduction in dose in steps of 12.5 mg over one to two weeks is recommended, if you have to stop treatment. Your doctor will advise you on how to reduce your daily dose. If you have to stop Zaponex treatment suddenly, you will have to be checked by your doctor.
If your doctor decides to re-start the treatment with Zaponex and your last dose of Zaponex was over two days ago, this will be with the starting dose of 12.5 mg.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Zaponex can cause side effects, although not everybody gets them.
Tell your doctor immediately before taking the next Zaponex tablet, if you experience any of the following:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from the available data):
If any of the above apply to you, please tell your doctor immediately before taking the next Zaponex tablet.
Very common (may affect more than 1 in 10 people):
Drowsiness, dizziness, increased production of saliva.
Common (may affect up to 1 in 10 people):
High level of white blood cells (leukocytosis), high level of a specific type of white blood cell (eosinophilia), weight gain, blurred vision, headache, trembling, stiffness, restlessness, jerks, abnormal movements, inability to initiate movement, inability to remain motionless, changes in ECG heart readings, high blood pressure, faintness or light-headedness after changing position, nausea (feeling sick), vomiting (being sick), loss of appetite, dry mouth, minor abnormalities in liver function tests, loss of bladder control, difficulty in passing urine, tiredness, fever, increased sweating, raised body temperature, speech disorders (e.g. slurred speech).
Uncommon (may affect up to 1 in 100 people):
Lack of white blood cells (agranulocytosis), speech disorders (e.g. stuttering).
Rare (may affect up to 1 in 1,000 people):
Low level of red blood cells (anaemia), restlessness, agitation, confusion, delirium, inflammation of the heart muscle (myocarditis) or the membrane surrounding the heart muscle (pericarditis), fluid collection around the heart (pericardial effusion), high level of sugar in the blood, diabetes mellitus, raised levels of an enzyme called creatinine phosphokinase in the blood.
Very rare (may affect up to 1 in 10,000 people):
Increase in numbers of blood platelets with possible clotting in the blood vessels, uncontrollable movements of mouth/tongue and limbs, obsessive thoughts and compulsive repetitive behaviours (obsessive compulsive symptoms), skin reactions, swelling in front of the ear (enlargement of saliva glands), difficulty in breathing, complications due to uncontrolled blood sugar (e.g. coma or ketoacidosis), very high levels of triglycerides or cholesterol in the blood, stopped heartbeat (cardiac arrest), sudden unexplained death.
Not known (frequency cannot be estimated from the available data)
Liver disorders including fatty liver disease, death of liver cells, liver toxicity/injury, liver disorders that involve replacement of normal liver tissue with scar tissue leading to loss of liver function, including those liver events leading to life-threatening consequences such as liver failure (which may lead to death), liver injury (injury of liver cells, bile duct in the liver, or both) and liver transplant, changes in brain waves readings (electroencephalogram/EEG), diarrhoea, stomach discomfort, heartburn, stomach discomfort after a meal, muscle weakness, muscle spasms, muscle pain, stuffy nose, nocturnal bedwetting, sudden, uncontrollable increase in blood pressure (pseudophaeochromocytoma), uncontrolled bending of the body to one side (pleurothotonus), ejaculatory disorder if you are a male, in which semen enters the bladder instead of ejaculating through the penis (dry orgasm or retrograde ejaculation), rash, purplish-red spots, fever or itching due to inflammation of blood vessel, inflammation of the colon resulting in diarrhoea, abdominal pain, fever, change in skin colour, “butterfly” facial rash, joint pain, muscle pain, fever and fatigue (lupus erythematous), restless legs syndrome (irresistible urge to move your legs or arms, usually accompanied by uncomfortable sensations during periods of rest, especially in the evening or at night and temporarily relieved by movement).
In elderly people with dementia, a small increase in the number of people dying has been reported for patients taking antipsychotics compared with those not taking antipsychotics.
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Zaponex after the expiry date [EXP] which is stated on the outer carton box and on each blister or on the label of the container. The first two digits indicate the month and the last four digits indicate the year. The expiry date refers to the last day of that month.
For the HDPE container: The medicinal product does not require any special storage conditions.
For the blister packs: Zaponex should be stored below 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is clozapine. Each tablet contains either 25 or 100 mg clozapine.
The other ingredients are: lactose monohydrate, povidone, pregelatinised starch, maize starch, talc, colloidal anhydrous silica, magnesium stearate.
The tablets are yellow and round, scored with a division mark on both sides and debossed with “CPN 25” or “CPN 100” on one side.
They are supplied in blister packs of 28, 30, 60, 84, 90 and 300 tablets or in plastic containers containing 500 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer(s):
National registration number:
Zaponex 25 mg Tablets PL 32553/0001
Zaponex 100 mg Tablets PL 32553/0002
This leaflet was last revised in June 2020